BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 21981029)

  • 1. KATP channel mutations in infants with permanent diabetes diagnosed after 6 months of life.
    Rubio-Cabezas O; Flanagan SE; Damhuis A; Hattersley AT; Ellard S
    Pediatr Diabetes; 2012 Jun; 13(4):322-5. PubMed ID: 21981029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular Genetics, Clinical Characteristics, and Treatment Outcomes of K
    Ngoc CTB; Dien TM; De Franco E; Ellard S; Houghton JAL; Lan NN; Thao BP; Khanh NN; Flanagan SE; Craig ME; Dung VC
    Front Endocrinol (Lausanne); 2021; 12():727083. PubMed ID: 34566892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of permanent neonatal diabetes in Slovakia and successful replacement of insulin with sulfonylurea therapy in KCNJ11 and ABCC8 mutation carriers.
    Stanik J; Gasperikova D; Paskova M; Barak L; Javorkova J; Jancova E; Ciljakova M; Hlava P; Michalek J; Flanagan SE; Pearson E; Hattersley AT; Ellard S; Klimes I
    J Clin Endocrinol Metab; 2007 Apr; 92(4):1276-82. PubMed ID: 17213273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Permanent neonatal diabetes due to activating mutations in ABCC8 and KCNJ11.
    Edghill EL; Flanagan SE; Ellard S
    Rev Endocr Metab Disord; 2010 Sep; 11(3):193-8. PubMed ID: 20922570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful sulfonylurea treatment of a neonate with neonatal diabetes mellitus due to a novel missense mutation, p.P1199L, in the ABCC8 gene.
    Oztekin O; Durmaz E; Kalay S; Flanagan SE; Ellard S; Bircan I
    J Perinatol; 2012 Aug; 32(8):645-7. PubMed ID: 22842804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutations in ATP-sensitive K+ channel genes cause transient neonatal diabetes and permanent diabetes in childhood or adulthood.
    Flanagan SE; Patch AM; Mackay DJ; Edghill EL; Gloyn AL; Robinson D; Shield JP; Temple K; Ellard S; Hattersley AT
    Diabetes; 2007 Jul; 56(7):1930-7. PubMed ID: 17446535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutations in the ABCC8 gene encoding the SUR1 subunit of the KATP channel cause transient neonatal diabetes, permanent neonatal diabetes or permanent diabetes diagnosed outside the neonatal period.
    Patch AM; Flanagan SE; Boustred C; Hattersley AT; Ellard S
    Diabetes Obes Metab; 2007 Nov; 9 Suppl 2(Suppl 2):28-39. PubMed ID: 17919176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutations of the same conserved glutamate residue in NBD2 of the sulfonylurea receptor 1 subunit of the KATP channel can result in either hyperinsulinism or neonatal diabetes.
    Männikkö R; Flanagan SE; Sim X; Segal D; Hussain K; Ellard S; Hattersley AT; Ashcroft FM
    Diabetes; 2011 Jun; 60(6):1813-22. PubMed ID: 21617188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activating mutations in the ABCC8 gene in neonatal diabetes mellitus.
    Babenko AP; Polak M; Cavé H; Busiah K; Czernichow P; Scharfmann R; Bryan J; Aguilar-Bryan L; Vaxillaire M; Froguel P
    N Engl J Med; 2006 Aug; 355(5):456-66. PubMed ID: 16885549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coexpression of the type 2 diabetes susceptibility gene variants KCNJ11 E23K and ABCC8 S1369A alter the ATP and sulfonylurea sensitivities of the ATP-sensitive K(+) channel.
    Hamming KS; Soliman D; Matemisz LC; Niazi O; Lang Y; Gloyn AL; Light PE
    Diabetes; 2009 Oct; 58(10):2419-24. PubMed ID: 19587354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and molecular characterization of neonatal diabetes and monogenic syndromic diabetes in Asian Indian children.
    Jahnavi S; Poovazhagi V; Mohan V; Bodhini D; Raghupathy P; Amutha A; Suresh Kumar P; Adhikari P; Shriraam M; Kaur T; Das AK; Molnes J; Njolstad PR; Unnikrishnan R; Radha V
    Clin Genet; 2013 May; 83(5):439-45. PubMed ID: 22831748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ATP-sensitive potassium channels--neonatal diabetes mellitus and beyond.
    Sperling MA
    N Engl J Med; 2006 Aug; 355(5):507-10. PubMed ID: 16885555
    [No Abstract]   [Full Text] [Related]  

  • 13. Personalized medicine switching from insulin to sulfonylurea in permanent neonatal diabetes mellitus dictated by a novel activating ABCC8 mutation.
    Mak CM; Lee CY; Lam CW; Siu WK; Hung VC; Chan AY
    Diagn Mol Pathol; 2012 Mar; 21(1):56-9. PubMed ID: 22306677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Switching from insulin to oral sulfonylureas in patients with diabetes due to Kir6.2 mutations.
    Pearson ER; Flechtner I; Njølstad PR; Malecki MT; Flanagan SE; Larkin B; Ashcroft FM; Klimes I; Codner E; Iotova V; Slingerland AS; Shield J; Robert JJ; Holst JJ; Clark PM; Ellard S; Søvik O; Polak M; Hattersley AT;
    N Engl J Med; 2006 Aug; 355(5):467-77. PubMed ID: 16885550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neonatal diabetes: an expanding list of genes allows for improved diagnosis and treatment.
    Greeley SA; Naylor RN; Philipson LH; Bell GI
    Curr Diab Rep; 2011 Dec; 11(6):519-32. PubMed ID: 21993633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Permanent neonatal diabetes mellitus: same mutation, different glycemic control with sulfonylurea therapy on long-term follow-up.
    Aydin BK; Bundak R; Baş F; Maraş H; Saka N; Günöz H; Darendeliler F
    J Clin Res Pediatr Endocrinol; 2012 Jun; 4(2):107-10. PubMed ID: 22672870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism of KATP hyperactivity and sulfonylurea tolerance due to a diabetogenic mutation in L0 helix of sulfonylurea receptor 1 (ABCC8).
    Babenko AP; Vaxillaire M
    FEBS Lett; 2011 Nov; 585(22):3555-9. PubMed ID: 22020219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutations in the ABCC8 (SUR1 subunit of the K(ATP) channel) gene are associated with a variable clinical phenotype.
    Klupa T; Kowalska I; Wyka K; Skupien J; Patch AM; Flanagan SE; Noczynska A; Arciszewska M; Ellard S; Hattersley AT; Sieradzki J; Mlynarski W; Malecki MT
    Clin Endocrinol (Oxf); 2009 Sep; 71(3):358-62. PubMed ID: 19021632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The genetic basis of neonatal diabetes mellitus.
    Sperling MA
    Pediatr Endocrinol Rev; 2006 Dec; 4 Suppl 1():71-5. PubMed ID: 17261973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An ATP-binding mutation (G334D) in KCNJ11 is associated with a sulfonylurea-insensitive form of developmental delay, epilepsy, and neonatal diabetes.
    Masia R; Koster JC; Tumini S; Chiarelli F; Colombo C; Nichols CG; Barbetti F
    Diabetes; 2007 Feb; 56(2):328-36. PubMed ID: 17259376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.